8-K: New Horizon Aircraft Restates Financials After Reclassifying Development Costs

New Horizon Aircraft has restated its financial statements for the year ended May 31, 2023, and interim periods due to a reclassification of deferred development costs to research and development expenses.

Summary

• New Horizon Aircraft has restated its audited financial statements for the year ended May 31, 2023, and unaudited interim financial statements for the period ended August 31, 2023.
• The restatement involves reclassifying previously capitalized deferred development costs as operating research and development costs.
• This change resulted in an increase in research and development expenses and a corresponding increase in net loss for the year ended May 31, 2023, by $77,207.
• The opening retained earnings for the period ended May 31, 2023, was reduced by $894,784.
• Total shareholders' equity and total assets for the period ended May 31, 2023, were reduced by $971,991.
• The company's net loss for the year ended May 31, 2023, was $1,246,899, compared to $1,739,122 in 2022.
• As of May 31, 2023, the company had negative working capital of $1,242,922 and an accumulated deficit of $6,523,124.
• The company's cash and cash equivalents were $227,969 as of May 31, 2023.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, including a restatement of financials, increased losses, negative working capital, and a going concern warning. While the company has promising technology, the financial situation is concerning from an investment perspective.

Positives

• The company received $300,434 in grant income during the year ended May 31, 2023.
• The company has developed and patented unique eVTOL technology.

Negatives

• The company has a history of losses and negative cash flows.
• The company has negative working capital of $1,242,922 as of May 31, 2023.
• The company has an accumulated deficit of $6,523,124 as of May 31, 2023.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company's financial statements for the year ended May 31, 2023, and interim periods should no longer be relied upon.

Risks

• The company is in the development stage and subject to risks including the need for successful product development and additional financing.
• The company faces competition from larger companies.
• The company is dependent on key individuals.
• The company may face patent litigation.
• The company's ability to continue as a going concern is in doubt due to losses and negative cash flows.

Future Outlook

Management expects losses and negative cash flows to continue for the foreseeable future, primarily as a result of continued research and development efforts.

Management Comments

• Management expects losses and negative cash flows to continue for the foreseeable future.
• Management believes that the company is not exposed to significant credit risk due to the financial position of the bank in which the cash and cash equivalents are held.
• Management has evaluated subsequent events through September 12, 2023.

Industry Context

The eVTOL industry is highly competitive and capital-intensive, with many companies in the development stage facing similar challenges related to funding, technology development, and regulatory approvals. New Horizon's restatement and going concern issues highlight the risks inherent in this sector.

Comparison to Industry Standards

• Many early-stage eVTOL companies are experiencing significant losses as they invest heavily in research and development, similar to New Horizon.
• The reclassification of development costs to R&D expenses is a common practice in the industry, aligning with accounting standards for companies in the development phase.
• The going concern issue is not uncommon for pre-revenue companies in the aerospace sector, as they rely heavily on external funding.
• Companies like Joby Aviation and Archer Aviation, while having raised significantly more capital, also report substantial losses as they progress through development and certification phases.

Related Party Transactions

• During the year ended May 31, 2023, the company issued $100,000 convertible promissory notes to its directors.
• During the year ended May 31, 2023, the company issued 523,500 options to its directors and recorded $41,254 stock-based compensation expenses accordingly.
• Salaries to officers were $534,023 in 2023 and $530,930 in 2022.
• Reimbursed expenses to officers were $8,013 in 2023 and $32,955 in 2022.

Stakeholder Impact

• Shareholders will be impacted by the restatement of financials and the going concern issue.
• Employees may be concerned about the company's financial stability.
• Creditors may be concerned about the company's ability to repay debts.
• Customers may be concerned about the company's ability to deliver on its products and services.

Next Steps

• The company needs to secure additional funding to continue operations.
• The company needs to successfully develop its eVTOL technology.
• The company needs to address the going concern issue.

Key Dates

Keywords

financial restatement, research and development, deferred development costs, eVTOL, going concern, net loss, negative working capital, accumulated deficit, audit committee, financial statements